The Global Chronic Obstructive Pulmonary Disease (COPD) Diagnosis Market is driven by rising smoking prevalence
Chronic Obstructive Pulmonary Disease (COPD) refers to a group of lung diseases that block airflow and make breathing difficult. It includes emphysema and chronic bronchitis. Common symptoms include shortness of breath, cough, mucus (sputum) production and wheezing. COPD is typically caused by significant exposure to noxious particles or gases, primarily from tobacco smoking. It usually gets gradually worse over time.
Treatment for Chronic Obstructive Pulmonary Disease (COPD) Diagnosis Market includes medications, pulmonary rehabilitation and sometimes surgery or a lung transplant. The global COPD treatment market consists of drugs such as bronchodilators, corticosteroids and combination therapies to prevent or treat symptoms.
The chronic obstructive pulmonary disease (COPD) diagnosis market is estimated to be valued at USD 2.18 billion in 2024 and is expected to reach USD 3.05 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.
Get more insights on: Chronic Obstructive Pulmonary Disease (COPD) Diagnosis Market
Get this Report in Japanese Language: 慢性閉塞性肺疾患（COPD）診断市場
Get this Report in Korean Language: 만성 폐쇄성 폐질환(COPD) 진단 시장
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian